Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib
Calithera Biosciences Announces Clinical Trial Collaboration to Evaluate IBRANCE (palbociclib) and talazoparib in Combination with CB-839
pharmaceutical-investing Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights
RUA GOLD Provides Exploration Update and 2026 Outlook for the Auld Creek Gold-Antimony Project, Reefton Goldfield
Juggernaut Announces Fully Funded 10,000 Meter Inaugural Drill Program on New District-Scale Gold Silver Copper Rich System at 100% Controlled Big One Property, Golden Triangle, B.C.
